PODESTA GROUP, INC. for EMD SERONO INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN New | — |
| SHARON COHEN New | — |
| ANTHONY PODESTA New | — |
| NICOLE C YOUNG New | — |
Medicare/Medicaid MMM
Medicare Issues S. 301 Physician Payments Sunshine Act of 2009 Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009 H.R. 444 340 B Program Improvement and Integrity Act of 2009 S. 1239 340 B Program Improvement and Integrity Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN | — |
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Budget/Appropriations BUD
LHHS Appropriations Drug importation H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 Comparative Effectiveness H. Con. Res. 85 H.R. 2847 Commerce, Justice, Science and Related Agencies Appropriations Act, 2010 (Drug Importation) H.R. 2892 Department of Homeland Security Appropriations Act, 2010 (Drug Importation) S. 1298 Department of Homeland Security Appropriations Act, 2010 (Drug Importation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| RANDALL GERARD | — |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Pharmacy PHA
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus |
| SHARON COHEN | — |
| COURTNEY HAGEN | — |
| ANDREW KAUDERS | Communications Dir., Senator Robert Menendez |
| ANTHONY PODESTA | — |
| DONNI TURNER New | Senior Staff Counsel, Sen. Max Cleland |
| NICOLE C YOUNG | — |
Copyright/Patent/Trademark CPT
S. 515 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| COURTNEY HAGEN | — |
| CLAUDIA JAMES | — |
| ANTHONY PODESTA | — |
| NICOLE C YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.